Roles of Toll-like Receptor Signaling in Inflammatory Bone Resorption.
Level 5 - mechanism / opinion, no new human data
Narrative review of in vitro and animal model mechanisms
PubMed 39336119 · doi:10.3390/biology13090692
What was done
This narrative review summarizes experimental mechanisms linking Toll-like receptor (TLR) signaling to inflammatory bone resorption, focusing on periodontal disease. It describes findings from in vitro osteoblast-osteoclast co-culture models, membrane-bound prostaglandin E synthase-1 (mPGES-1)-deficient mice, and in vivo local TLR ligand injection models.
What was found
The abstract provides no numerical data. Qualitatively, mPGES-1-deficient mice failed to develop LPS-induced bone resorption. In co-culture systems, ligands targeting TLR2/1, TLR2/6, TLR3, TLR4, and TLR5 promoted osteoclast differentiation alongside increased prostaglandin E2 (PGE2) and RANKL production. In vivo, local injection of TLR2/1, TLR2/6, and TLR3 ligands induced severe alveolar bone resorption.
Why it matters
The review outlines how diverse microbial patterns drive inflammatory osteoclastogenesis through PGE2 and RANKL upregulation, clarifying potential molecular targets to prevent alveolar bone loss in periodontitis.
Limits
The abstract reports no quantitative values, sample sizes, or formal systematic review methodology. The summarized findings are derived entirely from cell culture and rodent models, which cannot establish clinical efficacy or safety in humans.
Cited by
- context Lipopolysaccharide (LPS) induces bone inflammation that promotes osteoclast-mediated bone resorption over osteoblast activity, driving osteoporosis.